Raze Therapeutics is a biotechnology company dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic processes that drive cancer growth and survival. The company’s proprietary platform is based on new biological insights into how cancer cells reprogram cellular metabolism.
There is no investment information
No recent news or press coverage available for Raze Therapeutics, Inc..
We care about your data, and we'd love to use cookies make your experience better.
